2014年欧洲肝病学会丙型肝炎治疗推荐意见解读

Interpretation of 2014 European Association for the Study of Liver recommendations on treatment of hepatitis C

2014年欧洲肝病学会颁布了新版的丙型肝炎治疗推荐意见,更新和扩充了丙型肝炎的诊断、治疗目标和治疗终点、随访、治疗前的评估、适应证、不同基因型的治疗方案、严重肝病的治疗、特殊人群的治疗等。直接抗病毒药物—Sofosbuvir、Simeprevir和Daclatasvir带来了丙型肝炎治疗的新纪元。

The European Association for the Study of Liver issued the latest recommendations on treatment of hepatitis C in 2014,which updated and expanded the diagnosis of hepatitis C,goal and end-points of therapy,follow-up,pre-therapeutic assessment,indications,treatment of different genotypes,treatment of patients with severe liver disease,treatment of special groups. Additionally,Direct-acting antivirals,Sofosbuvir,Simeprevir and Daclatasvir,bring a new era for hepatitis C treatment.